lorlatinib,crizotinib
pfizer
['crown', 'lung', 'pfizer']
at #asco23, see an analysis of the phase 3 crown study examining the management of patients with alk+ non-small cell #lungcancer treated with alk inhibitors who received brain radiotherapy during the trial 9063 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ